vs
奎斯特诊断（DGX）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
奎斯特诊断的季度营收约是Roper Technologies的1.4倍（$2.9B vs $2.1B），Roper Technologies净利率更高（15.8% vs 9.7%，领先6.1%），Roper Technologies同比增速更快（11.3% vs 9.2%），过去两年Roper Technologies的营收复合增速更高（10.5% vs 9.9%）
奎斯特诊断是美国头部临床检验服务商，位列《财富》500强，业务覆盖美国、波多黎各、墨西哥及巴西，同时与全球范围内多家医院、诊所保持长期协作关系，为不同地区的客户提供专业临床检验相关服务。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
DGX vs ROP — 直观对比
营收规模更大
DGX
是对方的1.4倍
$2.1B
营收增速更快
ROP
高出2.1%
9.2%
净利率更高
ROP
高出6.1%
9.7%
两年增速更快
ROP
近两年复合增速
9.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.9B | $2.1B |
| 净利润 | $281.0M | $331.0M |
| 毛利率 | — | 69.4% |
| 营业利润率 | 15.4% | 27.2% |
| 净利率 | 9.7% | 15.8% |
| 营收同比 | 9.2% | 11.3% |
| 净利润同比 | 12.0% | 842.6% |
| 每股收益（稀释后） | $2.24 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGXROP
| Q1 26 | $2.9B | $2.1B | ||
| Q4 25 | $2.8B | $2.1B | ||
| Q3 25 | $2.8B | $2.0B | ||
| Q2 25 | $2.8B | $1.9B | ||
| Q1 25 | $2.7B | $1.9B | ||
| Q4 24 | $2.6B | $1.9B | ||
| Q3 24 | $2.5B | $1.8B | ||
| Q2 24 | $2.4B | $1.7B |
净利润DGXROP
| Q1 26 | $281.0M | $331.0M | ||
| Q4 25 | $245.0M | $428.4M | ||
| Q3 25 | $245.0M | $398.5M | ||
| Q2 25 | $282.0M | $378.3M | ||
| Q1 25 | $220.0M | $331.1M | ||
| Q4 24 | $222.0M | $462.3M | ||
| Q3 24 | $226.0M | $367.9M | ||
| Q2 24 | $229.0M | $337.1M |
毛利率DGXROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 32.4% | 69.5% | ||
| Q3 25 | 33.7% | 69.5% | ||
| Q2 25 | 34.2% | 69.2% | ||
| Q1 25 | 32.5% | 68.7% | ||
| Q4 24 | 32.7% | 68.3% | ||
| Q3 24 | 32.6% | 69.2% | ||
| Q2 24 | 33.5% | 69.5% |
营业利润率DGXROP
| Q1 26 | 15.4% | 27.2% | ||
| Q4 25 | 13.8% | 28.6% | ||
| Q3 25 | 13.7% | 28.4% | ||
| Q2 25 | 15.9% | 28.2% | ||
| Q1 25 | 13.0% | 27.9% | ||
| Q4 24 | 13.8% | 28.0% | ||
| Q3 24 | 13.3% | 28.1% | ||
| Q2 24 | 14.8% | 28.8% |
净利率DGXROP
| Q1 26 | 9.7% | 15.8% | ||
| Q4 25 | 8.7% | 20.8% | ||
| Q3 25 | 8.7% | 19.8% | ||
| Q2 25 | 10.2% | 19.5% | ||
| Q1 25 | 8.3% | 17.6% | ||
| Q4 24 | 8.5% | 24.6% | ||
| Q3 24 | 9.1% | 20.8% | ||
| Q2 24 | 9.6% | 19.6% |
每股收益（稀释后）DGXROP
| Q1 26 | $2.24 | $4.87 | ||
| Q4 25 | $2.18 | $3.97 | ||
| Q3 25 | $2.16 | $3.68 | ||
| Q2 25 | $2.47 | $3.49 | ||
| Q1 25 | $1.94 | $3.06 | ||
| Q4 24 | $1.95 | $4.29 | ||
| Q3 24 | $1.99 | $3.40 | ||
| Q2 24 | $2.03 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $393.0M | $382.9M |
| 总债务越低越好 | $5.7B | $9.7B |
| 股东权益账面价值 | $7.7B | $18.8B |
| 总资产 | $16.7B | $34.6B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资DGXROP
| Q1 26 | $393.0M | $382.9M | ||
| Q4 25 | $420.0M | $297.4M | ||
| Q3 25 | $432.0M | $320.0M | ||
| Q2 25 | $319.0M | $242.4M | ||
| Q1 25 | $188.0M | $372.8M | ||
| Q4 24 | $549.0M | $188.2M | ||
| Q3 24 | $764.0M | $269.6M | ||
| Q2 24 | $271.0M | $251.5M |
总债务DGXROP
| Q1 26 | $5.7B | $9.7B | ||
| Q4 25 | $5.2B | $9.3B | ||
| Q3 25 | $5.2B | — | ||
| Q2 25 | $5.2B | — | ||
| Q1 25 | $5.9B | — | ||
| Q4 24 | $5.6B | $7.6B | ||
| Q3 24 | $5.6B | — | ||
| Q2 24 | $3.8B | — |
股东权益DGXROP
| Q1 26 | $7.7B | $18.8B | ||
| Q4 25 | $7.2B | $19.9B | ||
| Q3 25 | $7.3B | $20.0B | ||
| Q2 25 | $7.2B | $19.6B | ||
| Q1 25 | $6.9B | $19.2B | ||
| Q4 24 | $6.8B | $18.9B | ||
| Q3 24 | $6.8B | $18.5B | ||
| Q2 24 | $6.6B | $18.1B |
总资产DGXROP
| Q1 26 | $16.7B | $34.6B | ||
| Q4 25 | $16.2B | $34.6B | ||
| Q3 25 | $16.2B | $34.6B | ||
| Q2 25 | $16.0B | $33.2B | ||
| Q1 25 | $15.8B | $31.4B | ||
| Q4 24 | $16.2B | $31.3B | ||
| Q3 24 | $16.1B | $31.6B | ||
| Q2 24 | $13.9B | $29.8B |
负债/权益比DGXROP
| Q1 26 | 0.74× | 0.52× | ||
| Q4 25 | 0.72× | 0.47× | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 0.83× | 0.40× | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.58× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $278.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | $507.0M |
| 自由现金流率自由现金流/营收 | — | 24.2% |
| 资本支出强度资本支出/营收 | 3.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DGXROP
| Q1 26 | $278.0M | — | ||
| Q4 25 | $465.0M | $738.0M | ||
| Q3 25 | $563.0M | $869.5M | ||
| Q2 25 | $544.0M | $404.1M | ||
| Q1 25 | $314.0M | $528.7M | ||
| Q4 24 | $464.0M | $722.2M | ||
| Q3 24 | $356.0M | $755.4M | ||
| Q2 24 | $360.0M | $384.1M |
自由现金流DGXROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $307.0M | — | ||
| Q3 25 | $419.0M | — | ||
| Q2 25 | $436.0M | — | ||
| Q1 25 | $197.0M | — | ||
| Q4 24 | $341.0M | — | ||
| Q3 24 | $250.0M | — | ||
| Q2 24 | $268.0M | — |
自由现金流率DGXROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 10.9% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 7.4% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 11.2% | — |
资本支出强度DGXROP
| Q1 26 | 3.9% | 0.5% | ||
| Q4 25 | 5.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 3.8% | — |
现金转化率DGXROP
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.90× | 1.72× | ||
| Q3 25 | 2.30× | 2.18× | ||
| Q2 25 | 1.93× | 1.07× | ||
| Q1 25 | 1.43× | 1.60× | ||
| Q4 24 | 2.09× | 1.56× | ||
| Q3 24 | 1.58× | 2.05× | ||
| Q2 24 | 1.57× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
